Atlas Trials

A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Clinical trial NCT07035626 · RECRUITING

Trial details

NCT number
NCT07035626
Sponsor
West China Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Radiation-induced Xerostomia
Start date
2025-06-25
Primary completion
2026-06-08
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.